References
For the antibiotically active C-glycosyl selenazole selenazofurin,
see:
1a
Goldstein BM.
Kennedy SD.
Hennen WJ.
J. Am. Chem. Soc.
1990,
112:
8265 ; and references cited therein
1b
Shafiee A.
Khashayarmanesh Z.
Kamal F.
J.
Sci., Islamic Repub. Iran
1990,
1:
11
1c
Shafiee A.
Shafaati A.
Khamench BH.
J.
Heterocycl. Chem.
1989,
26:
709
1d For cancerostatic activity
of 1,3-selenazoles see: Srivastava PC.
Robins RK.
J. Med. Chem.
1983,
26:
445
1e
Shafiee A.
Mazloumi A.
Cohen VJ.
J.
Heterocycl. Chem.
1979,
16:
1563
2a
Larsen R.
1,3-Selenazoles, In Comprehensive Heterocyclic Chemistry II,
, Shinkai I., Katritzky A., Rees C. W., Scriven E. F. V.
Vol.
3:
Elsevier Science;
Oxford:
1996.
Chap.
8.
2b
Wirth T.
Organoselenium Chemistry, in Modern Developments in Organic Synthesis
Springer;
Berlin:
2000.
3a
Koketsu M.
Nada F.
Ishihara H.
Synthesis
2002,
195
3b
Geisler K.
Jacobs A.
Künzler A.
Mattes M.
Girrleit I.
Zimmermann B.
Bulka E.
Pfeiffer W.-D.
Langer P.
Synlett
2002,
1983
3c
Kaminski R.
Glass RS.
Skowronska A.
Synthesis
2001,
1308
3d
Ishihara H.
Koketsu M.
Fukuta Y.
Nada F.
J. Am. Chem. Soc.
2001,
123:
8408
3e
Koketsu M.
Fukuta Y.
Ishihara H.
Tetrahedron
Lett.
2001,
42:
6333
3f
Zhang P.-F.
Chen Z.-C.
Synthesis
2000,
1219
3g
Maeda H.
Kambe N.
Sonoda N.
Fujiwara S.-i.
Sini-ike T.
Tetrahedron
1997,
53:
13667
3h
Lai L.-L.
Reid DH.
Synthesis
1993,
870
3i
Ogawa A.
Miyaka J.
Karasaki Y.
Murai S.
Sonoda N.
J.
Org. Chem.
1985,
50:
384
3j
Cohen VJ.
Synthesis
1978,
668
4
Haginiwa J.
Yakugaku
Zasshi
1948,
68:
191
5
Maeda H.
Kambe N.
Sonoda N.
Fujiwara S.-i.
Sini-ike T.
Tetrahedron
1997,
53:
13667 ; and references cited therein
6 For 2-benzoyl-1,3-benzoselenazole,
see: Mbuyi M.
Evers M.
Tihange G.
Luxen A.
Christiaens L.
Tetrahedron Lett.
1983,
5873
7
Synthesis of 2-Benzyl-4-phenyl-1,3-selenazole(3a). Typical Procedure. An EtOH solution
(20 mL) of α-bromoacetophenone (0.20 g, 1.0 mmol) and phenylseleno-acetic
amide (0.20 g, 1.0 mmol) was refluxed for 5 min. After cooling to
20 °C the precipitate was filtered off and recrystallized
from EtOH to give 3a as colourless needles (0.29
g, 99%), mp 99.5-100 °C. 1H
NMR (300 MHz, CDCl3): δ = 4.34
(s, 2 H, CH2), 7.31-7.90 (m, 10 H, Ar), 7.96 [s,
1 H, 2
J (SeH) = 51.3
Hz, 5-H, selenazole]. 13C
NMR (75 MHz, CDCl3): δ = 43.28,
118.86 [C-5, 1
J (C5Se) = 106.6 Hz],
126.62, 127.33, 127.75, 128.70, 128.87, 129.27, 135.51, 138.34,
155.78, 177.95. 77Se NMR (CDCl3, 60% Me2Se
in CDCl3): δ = 738.79.
IR (KBr): 1042 (s), 1125 (s), 1320 (w), 1420 (m), 1465 (m), 1520
(s), 3050 (w), 3080 (w) cm-1. MS (70
eV): m/z (%) = 298
(68) [M+], 182 (100), 102 (93).
Anal. Calcd for C16H13NSe (298.25): C, 64.44;
H, 4.39; N, 4.70. Found: C, 6.40; H, 4.20; N, 4.79. All products
gave correct spectroscopic data and correct elemental analyses and/or
high resolution mass data.
8
Synthesis of 2-Benzoyl-4-phenyl-1,3-selenazole
(
4a). Typical Procedure. To a dioxane
solution (20 mL) of 3a (1.49 g, 5.0 mmol)
was added SeO2 (0.55 g, 5.0 mmol) with stirring. The
mixture was heated in a water bath at 40 °C for 3
h. The hot solution was subsequently filtered, cooled, and poured
into ice water (50 mL). The crystalline precipitate was filtered
off, washed (H2O), dried in vacuo and recrystallized
(EtOH) to give 4a as yellow needles (1.09
g, 70%), mp 76-77 °C. 1H
NMR (300 MHz, CDCl3): δ = 7.38-8.62
(m, 10 H, ArH), 8.54 [s, 1 H, 2
J (SeH) = 50
Hz, 5-H, selenazole]. 13C
NMR (75 MHz, CDCl3): δ = 126.71, 126.77,
128.43, 128.93, 131.45, 133.63, 134.53, 134.92, 158.70, 175.08,
184.67. 77Se NMR (CDCl3, 60% Me2Se
in CDCl3): δ = 807.31.
IR (KBr): 840 (m), 901 (m), 1025 (w), 1050 (w), 1075 (w), 1110 (w),
1190 (m), 1270 (s), 1298 (s), 1430 (s), 1465 (s), 1505 (s) cm-1.
MS (70 eV): m/z (%) = 312 (24) [M+],
299 (3), 285 (2), 182 (10), 105 (100), 102 (17), 77 (63), 51 (16),
28 (14). Anal. Calcd for C16H11NOSe (312.22): C,
61.55; H, 3.55; N, 4.49. Found: C, 61.80; H, 3.90; N, 4.29.
9
Synthesis of 4,5-Diphenyl-1,3-selenazole
(
5e). Typical Procedure. An EtOH solution
(30 mL) of 2-benzoyl-4,5-diphenyl-1,3-selenazole (4e)
(1.65 g, 5 mmol) and NaOH (0.40 g, 10 mmol) was refluxed for 1 h.
After cooling, the sodium benzoate formed was filtered off and the
solution was poured into ice water. The product was filtered off,
dried in vacuo (P4O10) and recrystallized
from petroleum ether to give 5e as beige
needles (0.93 g, 77%), mp 73-74 °C. 1H NMR
(200 MHz, CDCl3): δ = 7.30-7.56
(m, 10 H, ArH), 9.86 [s, 1 H, 2
J (SeH) = 57.26
Hz, 2-H, selenazole]. 13C NMR
(50 MHz, CDCl3): δ = 127.59,
128.0, 128.34, 128.66, 129.35, 129.84, 133.96. 77Se NMR
(CDCl3, 60% Me2Se in CDCl3): δ = 806.24,
135.25,149.18, 150.85, 156.78. IR (KBr): 875 (m), 1080 (w), 1190
(w), 1270 (w), 1445 (s), 1495 (m), 1502 (m), 1605 (m), 3080 (m)cm-1.
MS (70 eV): m/z (%) = 285
(60) [M+], 257 (13), 204 (15)
, 178 (100). Anal. Calcd for C15H11NSe (284.22):
C, 63.39; H, 3.90; N, 4.93. Found: C, 63.21; H, 3.94; N, 4.93.
2-Unsubstituted 1,3-thiazoles have
been prepared by decarboxylation of 1,3-thiazolyl-2-carboxylic acids;
see for example:
10a
Sarodnick G.
Kempter G.
Pharmazie
1983,
38:
829
10b
Pirotte B.
Delarge J.
J. Chem. Res., Miniprint
1990,
7:
1634
10c
Strehlke P.
Chem.
Ber.
1973,
106:
721
10d
Sarodnick G.
Kempter G.
Z. Chem.
1979,
19:
21
11a
Geisler K.
Below H.
Möller A.
Bulka E.
Z.
Chem.
1984,
24:
99
11b For the synthesis of an
1,3-oxaseleno derivative, see: Weber M.
Hartmann H.
Z. Chem.
1987,
27:
95
12
Synthesis of Selenoformamide.
[11a]
To freshly
prepared P2Se5 (114.18 g, 250 mmol, see ref.
[3b]
) was added destilled formamide
(37.16 g, 825 mmol). The reaction mixture was stirred at 60 °C
for 5 h and was subsequently extracted with dry Et2O
for 8 h using a Soxhlet apparatus. The Et2O solution of
the extract was collected and the precipitated oil was separated,
filtered (to remove precipitated selenium) and dried in vacuo. The
oil solidified upon standing in the refrigerator. The solid was
recrystallized from Et2O to give 6 as
yellow needles, mp 35-37 °C. IR (KBr):
980 (m), 1095 (m), 1170 (m), 1305 (s), 1375 (s), 1415 (s), 1610
(s), 1680 (s), 2330 (w), 2780 (w), 3300 (s, br) cm-1.
Anal. Calcd for CH3NSe: C, 11.11; H, 2.80; N, 13.02.
Found: C, 11.40; H, 3.10; N, 13.11. The solidification of 6 can be achieved only for crude products
of good purity. Decomposition of selenoformamide (6)
occurred upon standing at 20 °C. However, it can
be stored at -20 °C for several days.
Freshly prepared material should be used for reactions.
13
Cyclization of
6 with 1d. To an EtOH solution of 6 (1.1
g, 10 mmol) was added 1d (2.4 g, 10 mmol)
and pyridine (0.79 g, 10 mmol). The solution was gently warmed,
the precipitate formed was filtered off and the filtrate was concentrated.
The product precipitated upon standing of the solution at 0 °C
and was recrystallized from dry i-PrOH
or EtOH to give 5d as slight yellow needles
(2.00 g, 79%), mp 160-162 °C.